Russia Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others

2018-12-01
Price :
Published : Dec-2018
No. of Pages : 45

Russia Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others

Summary

GlobalData’s new report, Russia Neurology Procedures Outlook to 2025, provides key procedures data on the Russia Neurology Procedures. The report provides procedure volumes within market categories – Dura Substitute Procedures, Hydrocephalus Shunting Procedures, ICP Procedures, Intracranial Stenting Procedures, Neuromodulation Procedures, Neurovascular Accessory Procedures, Neurovascular Coiling Assist Procedures, Neurovascular Embolization Procedures and Neurovascular Thrombectomy Procedures

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

– Russia Neurology Procedures volumes by categories – Dura Substitute Procedures, Hydrocephalus Shunting Procedures, ICP Procedures, Intracranial Stenting Procedures, Neuromodulation Procedures, Neurovascular Accessory Procedures, Neurovascular Coiling Assist Procedures, Neurovascular Embolization Procedures and Neurovascular Thrombectomy Procedures.
– Projections for each of the market categories. Data is provided from 2015 and forecast to 2025.
– Develop business and investment strategies by identifying the key market categories expected to register strong growth in the near future.
– Develop market-entry and market expansion strategies.

Reasons to buy

– Develop business and investment strategies by identifying the key market segment expected to register strong growth in the near future.
– Develop market-entry and market expansion strategies.

Filed in: Pharmaceutical, Therapeutics
Publisher : GlobalData
More Reports
Title Price Buy Now

Parkinson’s Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects

Parkinson's Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects Summary Parkinson's disease (PD), a progressive neurological disorder that affects movement control, is associated with considerable quality of life impairments and burden of care, particularly in the advanced disease stages. Cognitive and behavioral complications of PD are common. PD-associated dementia and PD-associated psychosis are both highly prevalent and associated with a large disease burden. There is a pressing unmet need within PD, PD-associated dementia, and PD-associated psychosis for more effective disease-modifying pharmacotherapies. Although current therapies can provide patients with symptomatic relie......
$6995

Obesity: Gut Hormone Receptors Retain Commercial Prominence

Obesity: Gut Hormone Receptors Retain Commercial Prominence Summary Obesity is a chronic and potentially fatal disease. The most prevalent metabolic disorder affecting people today, obesity requires multidisciplinary continuing treatment. Despite the market's clinical and regulatory challenges, the obesity pipeline is robust and contains a high level of diversity in both molecule types and molecular targets, which is in line with its multifactorial etiology. The primary concern within the market is the need for medications that adequately address the unmet clinical needs in the overweight and obese population, namely efficacious and safe therapies. This report assesses first-in-class innovation across the obesity pipeline. Scope - The obesity pipeline is robust and contains a high leve......
$6995

Hepatitis B: Competitive Landscape to 2027

Hepatitis B: Competitive Landscape to 2027 Summary Hepatitis B is a viral infection of the liver that can become chronic in young children, especially newborns to mothers with HBV infections, and people with compromised immune systems. Chronic hepatitis B is defined as measurable Hepatitis surface antigen (HBsAg) levels for more than six months after an acute infection. Despite the existence of prophylactic vaccines, hepatitis B remains a global public health threat, with approximately 257 million people worldwide living with chronic HBV infections. Chronic hepatitis B cannot be cured and patients have elevated risks of developing liver cirrhosis and hepatocellular carcinoma (HCC). This report provides an assessment of the pipeline, clinical, and commercial landscape of Hepatitis B. Ov......
$3495

Pediatric Vaccines: Epidemiology Forecast to 2028

Pediatric Vaccines: Epidemiology Forecast to 2028 Summary The administration of a vaccine, referred to as vaccination, elicits an immune response that prevents an individual from developing a specific disease when exposed to the corresponding infectious agent in the future. A successful vaccination results in immunization, where the individual is deemed immune to the disease. Routine immunization programs aim to protect children at an early age, when they are the most vulnerable to disease. Prior to the discovery of vaccines, several infectious diseases claimed the lives of millions of children each year. GlobalData epidemiologists utilized comprehensive, country-specific vaccination rate data from nationally representative public health surveillance systems and databases to arrive at ......
$3995

Chronic Spinal Cord Injury Global Clinical Trials Review, H1, 2019

Chronic Spinal Cord Injury Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Chronic Spinal Cord Injury Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Spinal Cord Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500

Cryptococcosis Global Clinical Trials Review, H1, 2019

Cryptococcosis Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Cryptococcosis Global Clinical Trials Review, H1, 2019" provides an overview of Cryptococcosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptococcosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500

Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2019

Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2019" provides an overview of Cognitive Impairment Associated With Schizophrenia (CIAS) clinical trials scenario. This report provides top line data relating to the clinical trials on Cognitive Impairment Associated With Schizophrenia (CIAS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials......
$2500

Cytopenia Global Clinical Trials Review, H1, 2019

Cytopenia Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Cytopenia Global Clinical Trials Review, H1, 2019" provides an overview of Cytopenia clinical trials scenario. This report provides top line data relating to the clinical trials on Cytopenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Global Clinical Trials Review, H1, 2019

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Global Clinical Trials Review, H1, 2019" provides an overview of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) clinical trials scenario. This report provides top line data relating to the clinical trials on Congenital Adrenal Hyperplasia (Adrenogenital Syndrome). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based ......
$2500

Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2019

Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Urticaria Or Hives clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Urticaria Or Hives. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy